SACERDOTI, David
 Distribuzione geografica
Continente #
NA - Nord America 8.253
EU - Europa 7.569
AS - Asia 7.531
SA - Sud America 992
AF - Africa 150
OC - Oceania 26
Continente sconosciuto - Info sul continente non disponibili 6
AN - Antartide 1
Totale 24.528
Nazione #
US - Stati Uniti d'America 8.078
SG - Singapore 3.688
RU - Federazione Russa 3.522
CN - Cina 1.649
GB - Regno Unito 980
BR - Brasile 766
IT - Italia 685
VN - Vietnam 685
HK - Hong Kong 643
FR - Francia 608
IE - Irlanda 541
KR - Corea 293
DE - Germania 292
UA - Ucraina 282
SE - Svezia 249
FI - Finlandia 151
BD - Bangladesh 138
ID - Indonesia 94
CA - Canada 91
IN - India 89
AR - Argentina 84
NL - Olanda 53
EC - Ecuador 49
MX - Messico 46
AT - Austria 37
TR - Turchia 36
JP - Giappone 34
ES - Italia 33
ZA - Sudafrica 33
PL - Polonia 32
CO - Colombia 28
AU - Australia 25
IQ - Iraq 25
TG - Togo 22
CL - Cile 21
BE - Belgio 18
PH - Filippine 18
BJ - Benin 17
PK - Pakistan 17
NG - Nigeria 16
EG - Egitto 13
PE - Perù 13
UZ - Uzbekistan 12
VE - Venezuela 12
AE - Emirati Arabi Uniti 11
PY - Paraguay 11
RO - Romania 11
LT - Lituania 10
DZ - Algeria 9
JO - Giordania 9
MA - Marocco 9
MY - Malesia 9
NP - Nepal 9
AZ - Azerbaigian 8
KE - Kenya 8
KZ - Kazakistan 8
SA - Arabia Saudita 8
AL - Albania 7
CZ - Repubblica Ceca 7
JM - Giamaica 7
CH - Svizzera 6
HN - Honduras 6
IL - Israele 6
OM - Oman 6
TN - Tunisia 6
DO - Repubblica Dominicana 5
HU - Ungheria 5
NO - Norvegia 5
UY - Uruguay 5
KW - Kuwait 4
QA - Qatar 4
SK - Slovacchia (Repubblica Slovacca) 4
BO - Bolivia 3
CR - Costa Rica 3
DK - Danimarca 3
IR - Iran 3
KG - Kirghizistan 3
LV - Lettonia 3
MD - Moldavia 3
PA - Panama 3
PS - Palestinian Territory 3
PT - Portogallo 3
RS - Serbia 3
SI - Slovenia 3
SN - Senegal 3
SY - Repubblica araba siriana 3
TH - Thailandia 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
AO - Angola 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BS - Bahamas 2
BY - Bielorussia 2
BZ - Belize 2
CW - ???statistics.table.value.countryCode.CW??? 2
CY - Cipro 2
ET - Etiopia 2
GE - Georgia 2
GT - Guatemala 2
Totale 24.493
Città #
Singapore 1.863
Ashburn 1.314
San Jose 1.053
Moscow 966
Southend 844
Jacksonville 789
Hong Kong 632
Dallas 587
Chandler 548
Dublin 539
The Dalles 455
Verona 375
Beijing 291
Council Bluffs 287
Lawrence 262
Princeton 262
Ho Chi Minh City 220
Wilmington 220
Los Angeles 167
Hanoi 137
Jinan 121
New York 111
Redondo Beach 111
Munich 105
Helsinki 103
Buffalo 102
Shenyang 81
Ann Arbor 80
Dong Ket 79
Santa Clara 79
São Paulo 72
Jakarta 63
Tianjin 61
Sindelfingen 59
Nanjing 52
Ningbo 51
Changsha 50
Milan 47
Orem 44
Haikou 41
Hebei 41
London 41
San Francisco 41
Hangzhou 40
Seattle 39
Columbus 38
Houston 37
Chennai 36
Guangzhou 36
Zhengzhou 34
Taizhou 32
Nuremberg 31
Tokyo 31
Brooklyn 30
Fairfield 30
Nanchang 30
Warsaw 29
Da Nang 28
Amsterdam 26
Frankfurt am Main 26
Boston 25
Taiyuan 25
Montreal 24
Norwalk 24
Toronto 24
Denver 23
Redwood City 23
Rome 23
Turku 23
Lomé 22
Rio de Janeiro 22
Stockholm 22
Falkenstein 21
Haiphong 21
Lanzhou 21
Washington 21
Guayaquil 20
Chicago 19
Johannesburg 19
Brussels 18
Mexico City 18
Cotonou 17
Phoenix 17
Lappeenranta 16
Vienna 16
Charlotte 15
Redmond 15
Atlanta 14
Brasília 14
Jiaxing 14
San Diego 14
Belo Horizonte 13
Biên Hòa 13
Curitiba 13
Manchester 13
Woodbridge 13
Abuja 12
Fuzhou 12
Romola 12
Ankara 11
Totale 14.721
Nome #
Correction to: Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study (Internal and Emergency Medicine, (2018), 13, 5, (651-660), 10.1007/s11739-018-1835-9) 269
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 210
ALTERAZIONI DEI PARAMETRI ECO-COLOR-DOPPLER SPLANCNICI DI IPERTENSIONE PORTALE NELLA CIRROSI BILIARE PRIMITIVA E NELLA COLANGITE SCLEROSANTE: CONFRONTO CON LA CIRROSI POST-EPATICA E ALCOLICA 201
11,12-Epoxyeicosatrienoic acid stimulates heme-oxygenase-1 in endothelial cells 197
11,12-EET increases porto-sinusoidal resistance and may play a role in endothelial dysfunction of portal hypertension 191
Prevalence of peripheral artery disease by abnormal ankle-brachial index in atrial fibrillation: implications for risk and therapy 159
Accuracy and predictive value of echo-Doppler measurements in acute liver rejection -- initial experience 151
Alterations in thyroid Doppler arterial resistance indices, volume and hormones in cirrhosis: Relationships with splanchnic haemodynamics 147
Interleukin-6: A New Marker of Advanced-Sarcopenic HCC Cirrhotic Patients 146
Arachidonic acid metabolites and endothelial dysfunction of portal hypertension 143
Alterazioni circolatorie splancniche e periferiche nella cirosi: studio mediante eco-color-doppler. Risultati a lungo termine del Centro Trapianti di Padova. 141
Arteroportal fistulas between the accessory right hepatic, gastroduodenal and superior mesenteric arteries and portal vein: a difficult technical problem to overcome in liver transplantation 141
Ankle-Brachial Index and cardiovascular events in atrial fibrillation: The ARAPACIS study 138
A Pig Model of Hemivascular Liver Occlusion for The Study of Ischemia-Reperfusion Injury: Use of an Infrared System for Detecting Ischemic Areas 138
Effects of direct-acting antiviral agents on lipid and glucose profile in HCV patients with type 2 diabetes: A real-life Italian experience 137
A Phase 2a active-comparator-controlled study to evaluate the efficacy and safety of efinopegdutide in patients with nonalcoholic fatty liver disease 136
Arterioportal fistulas in patients with liver cirrhosis: Usefulness of color-Doppler US for screening 133
Spur cells in liver cirrhosis are predictive of acute-on-chronic liver failure and liver-related mortality regardless of severe anaemia 132
Subclinical and clinical atherosclerosis in Non-alcoholic Fatty Liver Disease is associated with the presence of hypertension 131
Hepatic decompensation is the major driver of mortality in patients with HCC treated with atezolizumab plus bevacizumab: The impact of successful antiviral treatment 129
Carotid plaque detection improves the predictve value of CHA2DS2-VASc score in patients with non-valvular atrial fibrilation: The ARAPACIS Study 129
Metabolic-associated fatty liver disease and liver fibrosis scores as COVID-19 outcome predictors: a machine-learning application 127
A pathophysiological interpretation of unresponsiveness to spironolactone in a stepped-care ap¬proach to the diuretic treatment of ascites in non-azotemic cirrhotics 127
A CO-releaseng molecule, CORM-3, attenuates ischemia/reperfusion incurie in a new model in pig liver 127
Assessment of intrarenal sodium handling by lithium clearance in cirrhotic patients with ascites 126
I betabloccanti nel trattamento dell'ipertensione portale in corso di cirrosi epatica. Rapporti tra effetto sulla pressione portale e prevenzione della recidiva emorragica. 125
Bacterial infections as a risk factor for non-neoplastic portal vein thrombosis development in cirrhotic patients 123
Comparison of sublingual captopril and nifedipine in immediate treatment of hypertensive emergencies. A randomized, single-blind clinical trial 121
Atrogin-1 deficiency promotes cardiomyopathy and premature death via impaired autophagy 120
Alteration in endothelial function in cirrhosis 120
Hypoalbuminemia and Risk of Portal Vein Thrombosis in Cirrhosis 119
Frequency of Left Ventricular Hypertrophy in Non-Valvular Atrial Fibrillation 119
Serological response and breakthrough infection after COVID-19 vaccination in patients with cirrhosis and post-liver transplant 118
Duplex Doppler ultrasonography allows a multiorgan noninvasive approach to splanchnic pharmacodynamics in patients with cirrhosis 117
Prevalence of portal vein thrombosis in non-alcoholic fatty liver disease: a meta-analysis of observational studies 116
Effetti della ciclosporina sulla funzione renale e sul metabolismo renale citocromo P450-dipendente dell'acido arachidonico. 116
Waiting list mortality and 5-year transplant survival benefit of patients with MASLD: An Italian liver transplant registry study 116
Splenic Doppler impedance indeces: influence of different portal hemodynamic conditions. 112
Prevalence of portal vein thrombosis in non-alcoholic fatty liver disease: a meta-analysis of observational studies 112
Q-T interval prolongation in liver cirrhosis - Reversibility after orthotopic liver transplantation 111
Effetti del nadololo sull'emodinamica e sulla funzione renale, sul sistema renina-angiotensina-aldosterone e sulla produzione renale di PGE2 nei pazienti con cirrosi epatica ed ipertensione portale. 110
Differential effects of cyclosporine A on hepatic and renal cytocrom P450 dependent metabolism of arachidonic acid. 109
The multi-drug resistant organisms infections decrease during the antimicrobial stewardship era in cirrhotic patients: An Italian cohort study 108
Cholestatic HCV Cryoglobulinemia: A New Clinical and Pathological Entity before and after Direct-Acting Antiviral Therapies-A Case-Control Study 108
Alterazioni epatiche in corso di scompenso cardiaco 106
Heme-oxygenase-1 Induction Improves Type-1 Cardiorenal Syndrome Only In Mice With Impaired AngII-induced Lymphocyte Activation (SCID Mice) 105
Hepatofugal portal flow is highly predictive of acute-on-chronic liver failure: A new hemodynamic patho-physiological hypothesis 104
Comparison of computer psychometric tests (CPTs) and number connection test (NCT) in the detection of subclinical hepatic encephalophaty (SHE). 104
Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis 103
Effects of cyclosporine on renal function and cytochrome P450 -dependent metabolites of arachidonic acid metabolism 102
Magnesium deficiency (MD) in liver cirrhosis evaluated by intravenous load 102
Hepatic vein catheterization in the prognostic evaluation in cirrhotics with esophageal varices 102
Glomerular Hyperfiltration: A Marker of Fibrosis Severity in Metabolic Associated Steatotic Liver Disease in an Adult Population 100
Diagnostic accuracy of AGILE 3+ score for advanced fibrosis in patients with NAFLD: A systematic review and meta-analysis 100
Variability of atrial natriuretic peptide plasma levels in ascitic chirrotics; pathophysiological and clinical implications 100
Resistance to spironolactone in nonazotemic ascitic cirrhotic: role of enhanced proximal sodium reabsorption 100
Aumento degli indici di resistenza arteriosa epatica nella cirrosi con e senza trombosi portale: rapporti con l'ipertensione portale. 99
Effect of a dietary integration with BCAA or casein on nutritional state and lower limb amino acid exchange in cirrhosis 99
Effect of nadolol on liver haemodynamics and function in patients with cirrhosis 98
T Regulatory Lymphocytes Function Increased, by Induction Of Ho-1, Improves Type-1 Cardio-Renal Syndrome 98
Evaluation angiografique semiquantitative de la perfusion portale chez les cirrhotiques: relations avec le debit plasmatique hepatiqhe.[lettre] 98
SPLENO-SYSTEMIC SHUNTS AND COVERT HEPATIC ENCEPHALOPATY 98
Urinary excretion of P450-Hetes: increase of 20-Hete in patients with cirrhosis 96
Role of prostaglandins in the response to diuretic treatment of ascites in cirrhotic patients. 96
Myosteatosis is closely associated with sarcopenia and significantly worse outcomes in patients with cirrhosis 95
Differential effects of cyclosporine A on hepatic and renal cytocrome P450 dependent metabolism of arachidonic acid. 95
Confronto tra Captopril e Nifedipina per via sublinguale nel trattamento delle emergenze ipertensive. 95
Mesenteric arteries responsiveness to acute variations of wall shear stress is impaired in rats with liver cirrhosis 95
Incidence and Recurrence of Portal Vein Thrombosis in Cirrhotic Patients 94
Role of prostaglandins in the response to diuretic treatment of ascites in cirrhotic patients. 93
Relationship between renal prostaglandins and renal response to maximal water load in non ascitic liver cirrhosis. 93
Sistema vascolare epatico 93
HEPATIC VEINS DOPPLER PROFILE MODIFICATIONS DURING ACUTE PORTAL PRESSURE INCREASE INDUCED BY PARAUMBILICAL VEIN COMPRESSION 93
Platelets in Non-alcoholic Fatty Liver Disease 93
Effectiveness of a stepped care approach to diuretic treatment of ascites in cirrhotic patients 92
Chronic CO levels has a beneficial effect on vascular relaxation in diabetes 92
A MULTICENTER CONTROLLED-STUDY COMPARING BETA-BLOCKERS AND BETA-BLOCKERS PLUS NITRODERIVATIVES IN THE PRIMARY PROPHYLAXIS OF 1ST VARICEAL BLEEDING IN CIRRHOSIS - INTERIM ANALYSIS 91
Author's Reply: “Bacterial infections predispose to the development of portal vein thrombosis in patients with decompensated cirrhosis” 91
Left ventricular diastolic function in liver cirrhosis 91
Eicosanoid excretion in hepatic cirrhosis - Predominance of 20-HETE 91
Urinary excretion of P450-Hetes: increase of 20-Hete in patients with cirrhosis 91
Effect of chronic treatment with nadolol plus isosorbide mononitrate on liver blood flow and liver metabolic activity in cirrhosis 91
Renal cytochrome P450-dependent metabolism of arachidonic acid in experimental liver cirrhosis 90
Renal vasoconstriction in cirrhosis evaluated by duplex Doppler ultrasonography 90
Atrial natriuretic peptide (hANP) plasma levels in ascitic cirrhotics; a better selection of patients is needed ? 90
Drugs in the prevention of rebleeding in cirrhosis 90
Renal function in congestive heart failure. 90
Vascular disorders of the liver: recommendations from the Italian Association for the Study of the Liver (AISF) ad hoc committee 90
Myocardial overexpression of ANKRD1 causes sinus venosus defects and progressive diastolic dysfunction 90
La vasocostrizione renale in corso di cirrosi epatica: studio mediante eco-color doppler 89
Severe reduction of blood lysosomal acid lipase activity in cryptogenic cirrhosis: A nationwide multicentre cohort study 89
intrahepatic arterioportal fistulas in cirrhosis: usefulness of echo-Doppler as screening procedure 89
Comparison of Fondaparinux and Low-Molecular-Weight Heparin in the Treatment of Portal Vein Thrombosis in Cirrhosis 89
Absence of Viral Replication Is Associated With Improved Outcome in Anti-HCV-Positive Patients With Hepatocellular Carcinoma 88
Effetti del defribotide sulla funzione renale in ratti trattati conciclosporina 88
The safety of Sonovue in abdominal applications: retrospective analysis of 23188 investigations 88
Early Diagnosis of Type-2 Cardio-renal Syndrome by Doppler Sonographic Evaluation of Renal Vasoconstriction 88
Hepatitis C virus reinfection in liver transplant patients: evaluation of liver damage progression with echo-color doppler 88
Interobserver and inter-equipment variability of echo-Doppler evaluation of the superior mesenteric artery 88
PGE2 renali e metabolismo del sodio e dell'acqua nella cirrosi epatica anascitica 87
Totale 11.286
Categoria #
all - tutte 102.269
article - articoli 80.574
book - libri 987
conference - conferenze 15.805
curatela - curatele 0
other - altro 529
patent - brevetti 0
selected - selezionate 0
volume - volumi 4.374
Totale 204.538


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202198 0 0 0 0 0 0 0 0 0 0 0 98
2021/20221.598 104 209 11 23 111 21 54 116 108 116 238 487
2022/20232.483 283 156 347 236 379 701 15 101 162 10 49 44
2023/20241.224 52 86 86 113 70 198 129 77 2 63 251 97
2024/20254.564 298 280 183 803 163 51 110 480 523 244 361 1.068
2025/202612.455 1.149 687 692 1.848 2.728 880 1.327 976 906 604 241 417
Totale 24.961